4//SEC Filing
Orlinger Klaus 4
Accession 0001104659-20-004735
CIK 0001760542other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:06 PM ET
Size
11.7 KB
Accession
0001104659-20-004735
Insider Transaction Report
Form 4
Orlinger Klaus
Sr. VP, Research
Transactions
- Exercise/Conversion
Common Stock
2020-01-14$0.10/sh+7,358$736→ 7,358 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-01-14−7,358→ 0 totalExercise: $0.10Exp: 2026-12-31→ Common Stock (7,358 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-01-14−1,142→ 1,140 totalExercise: $0.10Exp: 2026-12-31→ Common Stock (1,142 underlying) - Exercise/Conversion
Common Stock
2020-01-14$0.10/sh+1,142$114→ 8,500 total - Sale
Common Stock
2020-01-14$11.30/sh−8,500$96,053→ 0 total
Footnotes (1)
- [F1]This option is fully vested and exercisable.
Documents
Issuer
HOOKIPA Pharma Inc.
CIK 0001760542
Entity typeother
Related Parties
1- filerCIK 0001768432
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 4:06 PM ET
- Size
- 11.7 KB